ClinicalTrials.govpublic full text
Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes
type 2 diabetes, insulin resistance, phosphodiesterase-5 inhibition, microdialysis, endothelial dysfunction, oral hypoglycaemic agents, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 904466
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.